Sargent Bickham Lagudis LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 232 filers reported holding SAGE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
Sargent Bickham Lagudis LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$5,000
-16.7%
850.0%0.00%
-100.0%
Q1 2021$6,000
-53.8%
85
-50.0%
0.00%0.0%
Q4 2020$13,000
+160.0%
170
+100.0%
0.00%0.0%
Q3 2020$5,000
+25.0%
850.0%0.00%
Q2 2020$4,000
+100.0%
850.0%0.00%
Q1 2020$2,000
-66.7%
850.0%0.00%
-100.0%
Q4 2019$6,000
-50.0%
850.0%0.00%0.0%
Q3 2019$12,000
-25.0%
850.0%0.00%
-50.0%
Q2 2019$16,000
+14.3%
850.0%0.00%0.0%
Q1 2019$14,000
+75.0%
850.0%0.00%
+100.0%
Q4 2018$8,000
-33.3%
850.0%0.00%0.0%
Q3 2018$12,000
-7.7%
850.0%0.00%
-50.0%
Q2 2018$13,000
-7.1%
850.0%0.00%0.0%
Q1 2018$14,0000.0%850.0%0.00%0.0%
Q4 2017$14,000
+180.0%
850.0%0.00%
+100.0%
Q3 2017$5,000
-28.6%
850.0%0.00%0.0%
Q2 2017$7,000
+16.7%
850.0%0.00%0.0%
Q1 2017$6,000
+50.0%
850.0%0.00%0.0%
Q4 2016$4,0000.0%850.0%0.00%0.0%
Q3 2016$4,000
+33.3%
850.0%0.00%
Q2 2016$3,0000.0%850.0%0.00%
Q1 2016$3,000850.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,966,688$120,204,00010.81%
Integral Health Asset Management, LLC 230,000$14,058,0004.30%
Asymmetry Capital Management, L.P. 102,462$6,262,0004.02%
ACUTA CAPITAL PARTNERS, LLC 225,000$13,752,0003.74%
DAFNA Capital Management LLC 158,306$9,676,0003.14%
Bain Capital Life Sciences Investors, LLC 499,100$30,505,0002.84%
Boxer Capital, LLC 1,094,000$66,865,0002.31%
Palo Alto Investors LP 590,200$36,073,0001.98%
Logos Global Management LP 250,000$15,280,0001.96%
Bellevue Group AG 1,579,504$96,539,0001.33%
View complete list of SAGE THERAPEUTICS INC shareholders